Delpharm group CDMO site in Huningue (Alsace, France), acquired from Novartis in 2011, with around 320 employees developing and manufacturing liquid, pasty and semi-solid medicines such as pediatric suspensions, hydroalcoholic solutions, suppositories and oral gels.
暂无评论。
留下您的评分和评论